Idiopathic Hypersomnia
Key Symptoms
Excessive daytime sleepiness (EDS)
Long nighttime sleep
Unrefreshing naps
Sleep inertia (or “sleep drunkenness”)
Cognitive dysfunction
Some people with IH also experience headaches, low blood pressure, or symptoms that overlap with mood disorders. However, these are not used as diagnostic criteria.
What Causes IH?
The word “idiopathic” means the cause is unknown. Researchers suspect there may be a problem with how the brain uses certain chemicals that regulate alertness and arousal, such as GABA (gamma-aminobutyric acid). Some studies suggest that people with IH may have an overactive GABA system, which could explain why their sleepiness is so hard to overcome. However, IH is not caused by poor sleep habits or laziness, and it is not simply a side effect of depression or anxiety.
IH is also not the same as narcolepsy. While both conditions involve excessive sleepiness, people with IH do not experience cataplexy (sudden muscle weakness) or the same REM sleep disruptions commonly seen in narcolepsy.
How Is IH Diagnosed?
- Sleep history and symptom tracking
- Polysomnography (overnight sleep study) to rule out other conditions like sleep apnea
- Multiple Sleep Latency Test (MSLT): A daytime test that measures how quickly a person falls asleep in a quiet environment. People with IH often fall asleep quickly but do not enter REM sleep during naps
Is There a Cure?
There is currently no cure for idiopathic hypersomnia, but treatment options are improving. The goal of treatment is to reduce excessive sleepiness and improve quality of life. Options may include:
- Low-sodium oxybate (Xywav): The first medication approved specifically for IH
- Stimulants or wake-promoting agents: Such as modafinil, armodafinil, or solriamfetol
- Lifestyle strategies: These may include consistent sleep routines, strategic scheduling, and support from accommodations at work or school
Living with IH
Living with idiopathic hypersomnia can be isolating and frustrating. Because the symptoms are invisible and not widely understood, many people with IH are misjudged or dismissed. Raising awareness and connecting with a supportive community can make a real difference.
At PWN4PWN, we believe your experience is real and valid. We are here to support people with idiopathic hypersomnia, amplify their voices, and push for better research, treatments, and recognition.
Current Challenges in Diagnosing Idiopathic Hypersomnia
Lack of Reliable Objective Biomarkers
- There are no established neurobiological markers for idiopathic hypersomnia (IH), so diagnosis relies heavily on self-reported symptoms and exclusion of other causes.
Impact of Medications and Comorbidities
- Medications (especially those affecting REM sleep) and comorbid conditions can confound test results, requiring careful management before diagnostic testing.
Underrecognition and Delayed Diagnosis
- IH is often underrecognized due to its rarity and overlap with more common sleep disorders, leading to delays in care and increased burden for patients.
Challenges with Current Diagnostic Criteria
- The International Classification of Sleep Disorders (ICSD-3) criteria are seen as insufficiently nuanced, lacking ways to grade diagnostic certainty or measure long sleep time.
- Some proposed improvements, such as multi-day/night sleep studies to measure extended sleep time, are logistically challenging and not widely available.
Symptom Overlap and Clinical Heterogeneity
- IH symptoms overlap with those of NT2 and other sleep disorders, making differentiation challenging.
- The disorder is rare and clinically heterogeneous, which can make recognition and diagnosis difficult even for experienced clinicians.
Exclusion of Other Conditions
- Diagnosis requires meticulous exclusion of other causes of excessive daytime sleepiness, such as sleep deprivation, obstructive sleep apnea, circadian rhythm disorders, depression, and medication effects.
- This process is time-consuming and often leads to significant diagnostic delays—sometimes up to 9 years.
Limitations of Diagnostic Tests
- The Multiple Sleep Latency Test (MSLT), a cornerstone of diagnosis, has limited sensitivity and reliability for IH. Up to half of people with IH may have normal results on standard sleep studies.
- The MSLT can yield inconsistent results, and repeated testing may change a patient’s diagnosis between IH and narcolepsy type 2 (NT2).
- Current protocols often do not capture total sleep time over 24 hours, which is important for distinguishing IH from other hypersomnias.
Get All The Support You Need!
- Engage in meaningful discussions
- Access expert-led video series
- Participate in interactive Q&A sessions
- Enjoy a secure, ad-free community
